Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD)

Thrombosis and Haemostasis

Volumn 78, Issue 2, 1997, Pages 926-929

  Meade, Thomas W ^a   Cooper, Jackie A ^a   Miller, George J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; FIBRINOGEN;

ADULT; ARTICLE; FOLLOW UP; HUMAN; HUMAN CELL; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOGENESIS; THROMBOSIS;

EID: 0030841894     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657653     Document Type: Article

References (15)

1. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ. Epidemiological characteristics of platelet aggregability. BMJ 1985; 290: 428-32.
2. Elwood PC, Beswick AD, Sharp DS, Yarnell JWG, Rogers S, Renaud S. Whole blood impedance platelet aggregometry and ischaemic heart disease. Arteriosclerosis 1990; 10: 1032-6.
3. Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322: 1549-54.
4. Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-11.
5. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84: 613-7.
6. Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-7.
7. Public health in Europe. No. 5: myocardial infarction community registers. Copenhagen, Denmark: World Health Organization, 1977.
8. Vickers MV, Thompson SG. Sources of variability in dose response platelet aggregometry. Thromb Haemost 1985; 53: 219-20.
9. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1995; 84 : 601-7.
10. Thompson SG, Vickers MV. Methods in dose response platelet aggregometry. Thromb Haemost 1985; 53: 216-8.
11. Hopkins A. BMDP 2L: Survival analysis with covariates - Cox models. In: Dixon WJ, ed BMDP statistical software. Berkeley: University of California Press 1988: 719-43.
12. Saniabadi AR, Lowe GDO, Barbenel JC, Forbes CD. A comparison of spontaneous platelet aggregation in whole blood with platelet rich plasma: additional evidence for the role of ADP. Thromb Haemost 1984; 51: 115-8.
13. Begent NA, Zawilska M, Born GVR. Effect of ADP-utilising enzymes on the arterial bleeding time in rats and rabbits. Br J Haematol 1982; 50: 317-25.
14. Nurden P, Savi P, Heilmann E et al. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. J Clin Invest 1995; 95: 1612-22.
15. Meade TW, Vickers MV, Thompson SG, Seghatchian MJ. The effect of physiological levels of fibrinogen on platelet aggregation. Thrombos Res 1985; 38: 527-34.